Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tenax Therapeutics Inc (NASDAQ:TENX)

0.5799
Delayed Data
As of Jun 23
 -0.0191 / -3.19%
Today’s Change
0.41
Today|||52-Week Range
2.77
-70.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues92.7K25.7K0.000.00
 
 
 
Cost of Goods Sold43.1K129.8K0.000.00
 
 
 
Depreciation And Amortization154.0K156.2K148.1K19.0K
 
 
 
 
 
 
Operating ExpensesGross Income-104.4K-260.3K-148.1K-19.0K
 
 
 
 
 
General Expenses6.0M16.6M13.5M19.4M
 
 
 
 
 
Research And Development2.4M3.0M6.6M13.1M
 
 
 
 
 
Total Operating Expenses6.2M16.9M13.7M19.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.1M-16.9M-13.7M-19.4M
 
 
 
 
 
Extraordinary Credit0.00--382.4K298.2K
 
 
 
Extraordinary Charge-248.0K-721.8K-1.2M-33.3M
 
 
 
 
 
Interest Expense On Debt4.2M2.2M49.1K0.00
 
 
 
 
Other Expenses1.2M266.4K57.9K74.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.4M-19.5M-14.1M-51.9M
 
 
 
 
 
Income Taxes0.000.000.00-8.0M
 
 
Preferred Dividend-958.1K-5.8M0.000.00
 
 
 
Net Income-9.4M-19.5M-14.1M-43.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.7M9.4M28.1M28.1M
 
 
 
 
 
Shares To Calculate EPS Diluted1.8M9.4M28.1M28.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$133.60-$2.71-$0.50-$1.56
 
 
 
 
 
EPS Diluted-$6.68-$2.71-$0.50-$1.56